Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
In May 2026, At the EASL Congress 2026, MetaVia presented promising late-breaking Phase 1 clinical trial results for DA-1726, an investigational dual GLP-1 and glucagon receptor agonist under development for obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
The rise of a new class of powerful, FDA-approved medications-specifically Wegovy Michigan and Zepbound Michigan -has completely reshaped the landscape of Detroit weight loss
EBOO Therapy for Lyme Disease: Advanced Treatment London For many, a Lyme disease diagnosis begins a cycle of antibiotics that offer only temporary relief
The peptide itself GHK consists of three amino acids: glycine (G), histidine (H), and lysine (K)
US$ 23.73
US$ 24.15
US$ 25.07
US$ 21.47
US$ 21.12
US$ 29.15
